15 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Article Searches
Monfort Cos. wants to demolish El Chapultepec building. Historic preservationists are fighting it. https://www.denverpost.com/2024/03/12/el-chapultepec-historic-preservation-petition-demolition-monfort-companies/ Mar 12, 2024 - Historic Denver this week filed an application for historic protection of the property at 1962 Market St.
Avadel surges after royalty rate awarded to Jazz in patent dispute lower than requested (update) https://seekingalpha.com/news/4075588-avadel-drops-after-jury-rules-in-favor-of-jazz-pharmaceuticals-in-patent-dispute?source=feed_sector_healthcare Mar 04, 2024 - Avadels stock seesawed after a jury ruled in favor of Jazz Pharmaceuticals in a patent dispute over a sleep disorder drug.
Jazz (JAZZ) Q3 Earnings Lag, Revenues in Line With Estimates https://www.zacks.com/stock/news/2233984/jazz-jazz-q3-earnings-lag-revenues-in-line-with-estimates?cid=CS-ZC-FT-analyst_blog|earnings_article-2233984 Feb 29, 2024 - Jazz's (JAZZ) fourth-quarter earnings miss estimates while sales meet the mark. Shares drop 1.5% post the announcement.
Here's What Key Metrics Tell Us About Jazz (JAZZ) Q4 Earnings https://www.zacks.com/stock/news/2233496/here-s-what-key-metrics-tell-us-about-jazz-jazz-q4-earnings?cid=CS-ZC-FT-fundamental_analysis|nfm-2233496 Feb 28, 2024 - The headline numbers for Jazz (JAZZ) give insight into how the company performed in the quarter ended December 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Jazz Pharmaceuticals (JAZZ) Q4 Earnings Lag Estimates https://www.zacks.com/stock/news/2233401/jazz-pharmaceuticals-jazz-q4-earnings-lag-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2233401 Feb 28, 2024 - Jazz (JAZZ) delivered earnings and revenue surprises of -4.56% and 0.37%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Exploring Analyst Estimates for Jazz (JAZZ) Q4 Earnings, Beyond Revenue and EPS https://www.zacks.com/stock/news/2230836/exploring-analyst-estimates-for-jazz-jazz-q4-earnings-beyond-revenue-and-eps?cid=CS-ZC-FT-fundamental_analysis|nfm_preview-2230836 Feb 23, 2024 - Besides Wall Street's top -and-bottom-line estimates for Jazz (JAZZ), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended December 2023.
Axsome (AXSM) Stock Falls Despite Q4 Earnings & Revenue Beat https://www.zacks.com/stock/news/2229451/axsome-axsm-stock-falls-despite-q4-earnings-revenue-beat?cid=CS-ZC-FT-analyst_blog|earnings_article-2229451 Feb 21, 2024 - Axsome (AXSM) stock declines despite narrower-than-expected loss in the fourth quarter of 2023. Its sales also beat estimates.
JAZZ Boosts Oncology Pipeline With KRAS Inhibitor Program https://www.zacks.com/stock/news/2223497/jazz-boosts-oncology-pipeline-with-kras-inhibitor-program?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2223497 Feb 08, 2024 - JAZZ inks a deal to acquire global rights to Redx Pharma's KRAS inhibitor program to strengthen its early-stage oncology pipeline.
Swig named the official Soda Shop of Utah Jazz https://www.nrn.com/regional-chains/swig-named-official-soda-shop-utah-jazz Feb 06, 2024 - Take note, soda fans: when the ‘jazz win, you win’ with a free swig treat the day after the game
'We have scouts all over the world': Former NBA All-Star Danny Ainge takes a money shot for global talent https://www.cnbc.com/2024/01/20/former-nba-all-star-danny-ainge-sees-demand-for-international-players.html Jan 20, 2024 - Utah Jazz CEO Danny Ainge seeks to capitalize on heightened international interest in the NBA.

Pages: 12

Page 1